457 related articles for article (PubMed ID: 29990503)
1. PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells.
Georgilis A; Klotz S; Hanley CJ; Herranz N; Weirich B; Morancho B; Leote AC; D'Artista L; Gallage S; Seehawer M; Carroll T; Dharmalingam G; Wee KB; Mellone M; Pombo J; Heide D; Guccione E; Arribas J; Barbosa-Morais NL; Heikenwalder M; Thomas GJ; Zender L; Gil J
Cancer Cell; 2018 Jul; 34(1):85-102.e9. PubMed ID: 29990503
[TBL] [Abstract][Full Text] [Related]
2. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
[TBL] [Abstract][Full Text] [Related]
4. Skipping of exon 10 in
Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
[TBL] [Abstract][Full Text] [Related]
5. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
He X; Yuan C; Yang J
Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
[TBL] [Abstract][Full Text] [Related]
6. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
Jo YK; Roh SA; Lee H; Park NY; Choi ES; Oh JH; Park SJ; Shin JH; Suh YA; Lee EK; Cho DH; Kim JC
Cancer Lett; 2017 Jan; 385():21-27. PubMed ID: 27836735
[TBL] [Abstract][Full Text] [Related]
7. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
[TBL] [Abstract][Full Text] [Related]
8. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
[TBL] [Abstract][Full Text] [Related]
9. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
Takahashi H; Nishimura J; Kagawa Y; Kano Y; Takahashi Y; Wu X; Hiraki M; Hamabe A; Konno M; Haraguchi N; Takemasa I; Mizushima T; Ishii M; Mimori K; Ishii H; Doki Y; Mori M; Yamamoto H
Mol Cancer Ther; 2015 Jul; 14(7):1705-16. PubMed ID: 25904505
[TBL] [Abstract][Full Text] [Related]
10. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.
Izaguirre DI; Zhu W; Hai T; Cheung HC; Krahe R; Cote GJ
Mol Carcinog; 2012 Nov; 51(11):895-906. PubMed ID: 21976412
[TBL] [Abstract][Full Text] [Related]
11. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer.
Mochizuki Y; Funayama R; Shirota M; Kikukawa Y; Ohira M; Karasawa H; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Int J Cancer; 2021 Nov; 149(10):1787-1800. PubMed ID: 34346508
[TBL] [Abstract][Full Text] [Related]
12. A developmentally regulated spliced variant of PTBP1 is upregulated in type 1 diabetic hearts.
Belanger K; Nutter CA; Li J; Yu P; Kuyumcu-Martinez MN
Biochem Biophys Res Commun; 2019 Feb; 509(2):384-389. PubMed ID: 30594394
[TBL] [Abstract][Full Text] [Related]
13. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
[TBL] [Abstract][Full Text] [Related]
14. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Exon 8/8a Splicing by Downregulated PTBP (Polypyrimidine Tract-Binding Protein) 1 Increases Ca
Lei J; Liu X; Song M; Zhou Y; Fan J; Shen X; Xu X; Kapoor I; Zhu G; Wang (王觉进) J
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2440-2453. PubMed ID: 32787518
[TBL] [Abstract][Full Text] [Related]
16. A miR-194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma.
Kang H; Heo S; Shin JJ; Ji E; Tak H; Ahn S; Lee KJ; Lee EK; Kim W
J Pathol; 2019 Nov; 249(3):395-408. PubMed ID: 31301177
[TBL] [Abstract][Full Text] [Related]
17. UnSASPing Senescence: Unmasking Tumor Suppression?
Schmitt CA
Cancer Cell; 2018 Jul; 34(1):6-8. PubMed ID: 29990502
[TBL] [Abstract][Full Text] [Related]
18. A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1.
Hollander D; Donyo M; Atias N; Mekahel K; Melamed Z; Yannai S; Lev-Maor G; Shilo A; Schwartz S; Barshack I; Sharan R; Ast G
Genome Res; 2016 Apr; 26(4):541-53. PubMed ID: 26860615
[TBL] [Abstract][Full Text] [Related]
19. Endothelial deletion of PTBP1 disrupts ventricular chamber development.
Liu H; Duan R; He X; Qi J; Xing T; Wu Y; Zhou L; Wang L; Shao Y; Zhang F; Zhou H; Gu X; Lin B; Liu Y; Wang Y; Liu Y; Li L; Liang D; Chen YH
Nat Commun; 2023 Mar; 14(1):1796. PubMed ID: 37002228
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response.
Huan L; Guo T; Wu Y; Xu L; Huang S; Xu Y; Liang L; He X
Mol Cancer; 2020 Jan; 19(1):11. PubMed ID: 31964396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
